Updated Jul 16, 2026
Stuglik Brian M has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $68K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 8.1K | $7.20 | $58K |
| 2026-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | A — Grant or award | 27.0K | $0.00 | |
| 2026-05-26 | VSTM | Verastem, Inc. | A — Grant or award | 36.0K | $0.00 | |
| 2025-09-16 | VSTM | Verastem, Inc. | S — Open-market sale | 587 | $9.99 | $6K |
| 2024-12-20 | VSTM | Verastem, Inc. | S — Open-market sale | 334 | $4.37 | $1K |
| 2024-12-20 | VSTM | Verastem, Inc. | S — Open-market sale | 595 | $4.54 | $3K |
Stuglik Brian M is a corporate insider — currently tracked as Director of PUMA BIOTECHNOLOGY, INC. (PBYI). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($68K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Stuglik Brian M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.